Drugs Made In America Acquisition II Corp. Rights (DMIIR)
Market Closed
16 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 08
+0
+3.0864%
$
6.93M Market Cap
- P/E Ratio
- Div Yield
2,515 Volume
- Eps
$ 0.08
Previous Close Want to track DMIIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made In America Acquisition II Corp. Rights (DMIIR) Statistics
Valuation metrics
Market Cap 6.93M
Enterprise value 7.04M
Trailing P/E (ttm) 0.74
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.01
Enterprise Value/Revenue -
Enterprise Value/EBITDA -5.57
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.78K
Average volume (90 days) 19.51K
Price summary
52-Week low 0.06
52-Week high 0.17
Beta -
50-Day moving average 0.08
200-Day moving average 0.1
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.02%
Return on equity 0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 0.53%
Book value per share (mrq) 7.72
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
